Sources | Names Used |
---|---|
CTRPv2 | SNX-2112:bortezomib (250:1 mol/mol) |
PharmacoGx | SNX-2112:bortezomib (250:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | DNAJC9 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.01 |
mRNA | HELLS | CTRPv2 | pan-cancer | AAC | 0.083 | 0.01 |
mRNA | LRRIQ3 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.01 |
mRNA | SYNPO2 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.01 |
mRNA | CD81 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.01 |
mRNA | ZNF384 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.01 |
mRNA | CNPPD1 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.01 |
mRNA | PI4K2A | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |
mRNA | TMOD1 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
mRNA | GPR22 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.01 |